In human breast cancer, high expression of AhRR, the dedicated AhR repressor, independently predicts prolonged metastasis-free survival (Vacher et al., 2018), in agreement with our findings in PyMT mice (Vogel et al., 2021). This evidence concerns the gene AHR and breast carcinoma.